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Figure S1. SEM images of a) DCA@Zr-L1 small and b) DCA@Zr-L2 small . The porosity of the samples was determined by N 2 sorption/desorption isotherms. The four terephthalate MOFs present type IV isotherms ( Figure S6 ) with H2 hysteresis loops, which are typical of interconnected networks of pores with different size and shape and suggest highly defective structures. S4 The fact that the hysteresis closes before 0.9 P/P 0 in all cases, in contrast to H3 hysteresis loops, which are typical of aggregates of particles, strongly suggests that the hierarchical porosity is a consequence of attachment of DCA modulators and resulting missing linker and cluster defects, although some contribution of inter-particle space should also be considered. Comparison of the N 2 uptake isotherms with those of DCA@Zr-L5 and DCA@Zr-L6 ( Figure   S7 ) shows that while the uptakes in the micropore region for the small samples are lower than typical UiO-66 materials, the defectivity induces pore volumes similar to DCA@Zr-L6.
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This difference is also borne out in the pore size distributions (PSDs, Figure S8 ) which show well defined micropores of expected size for DCA@Zr-L5 and DCA@Zr-L6 but, broad flat profiles for the DCA@Zr-LX small samples, showing the lack of micropore structure in the small nanoparticulate MOFs, with appreciable mesoporosity. NMR spectrum for digested DCA@Zr-L1 small is shown as an exemplar in Figure S9 ; the resonance at  = ~6.5 ppm corresponds to the -CCl 2 H proton of DCA. It is not possible to quantitatively determine DCA loading values from the NMR spectra alone, as the exact composition of the MOF will depend on defectivity and the replacement of MOF linkers with capping DCA molecules. However, estimating the molar ratio of DCA compared to the ligand gives a qualitative assessment of the extent of DCA incorporation (Table S2 ). Fourier transform infrared (FTIR) spectra were collected for the MOFs and compared to those of empty analogues and DCA ( Figure S10 ). FT-IR spectra of the DCA@MOFs show appearance of a new band in the carboxylic acid region, characteristic of DCA carboxylic acid, but shifted when compared to free DCA, possibly as a consequence of its attachment to Zr units. The presence of a new band associated to the C-Cl stretch (800 cm Thermogravimetric analysis (TGA) of the samples ( Figure S11 ) shows mass loss events which are not characteristic of the NMOF structure itself, but of DCA thermal decomposition.
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Figure S11. TGA traces in air of DCA loaded MOFs compared to empty MOFs for a)
DCA@Zr-L1 small , b) DCA@Zr-L2 small , c) DCA@Zr-L3 small , d) DCA@Zr-L4 small , e) DCA@Zr-L5, and f) DCA@Zr-L6.
DCA mass loss events within the MOF occur at a higher temperate that free DCA thermal decomposition (198°C), S5 as a consequence of its attachment to the Zr clusters. Mass loss events occurring before 225 °C are characteristic of DMF incorporation and water loss from S13 the structure, which is observed for both empty and DCA-containing MOFs, more notably for empty MOFs, as DMF coming from the synthetic process can get incorporated to the Zr 6 , as well as formic acid from DMF hydrolysis during the reaction. S2 However, DCA mass loss events from 250-375 °C can be easily identified in the trace and the first derivative, allowing DCA content to be quantified, and in agreement with the 1 H NMR spectra ( Figure S9 ) and FTIR spectra ( Figure S10 ) which also show DCA is present.
To investigate the composition of the materials, the theoretical mass loss attributed to both linker and DCA for different model structures, in which DCA displaces the linkers in the structure, was calculated (Table S3 ) and compared to the experimental thermal decomposition ( Table S4 ). Note that this approximation simply substitutes one linker molecule for one DCA molecule (steric hindrance suggests it would not be possible for two DCA molecules to replace one terephthalate linker) and one OH -to charge balance. This model does not account for missing linker or cluster defects or other deviations from an ideal structure. 
S3. Synthesis of DCA@MOFs of Larger Size
DCA@UiO-66 derivatives synthesis was performed following the former coordination modulation protocol, using a 1:1 ratio of ZrCl 4 and linker and adding 10 equivalents of DCA instead to the syntheses, together with 1 equivalent of HCl. After 24 hours, the reaction mixtures were cooled to room temperature and the NMOFs were collected with centrifugation and washed with DMF (x1) and MeOH (x3) by dispersion centrifugation cycles.
PXRD patterns ( Figure S12 ) show highly crystalline and phase pure MOFs with the UiO-66 topology. Figure S12 . Stacked PXRD patterns of the larger terephthalate MOFs, DCA@Zr-L1 -DCA@Zr-L4, compared to the predicted pattern for Zr-L1.
SEM imaging (Figures S13 and S14) showed the particles to be around 75-150 nm in diameter, with particle size distributions ( Figure S15 ) showing that DCA@Zr-L1 and DCA@Zr-L4 are slightly smaller than DCA@Zr-L2 and DCA@Zr-L3. Particle size data is presented in Table S5 . S16 Figure S13 . SEM images of a) DCA@Zr-L1 and b) DCA@Zr-L2. The samples' porosity was analysed by N 2 adsorption and desorption measurements ( Figure   S16 ), which ultimately confirmed DCA incorporation through binding to the Zr 6 clusters, as the samples present higher BET surface areas and pore volumes (Table S5) comparison between the spectra of DCA@Zr-L1 small and DCA@Zr-L1 is given in Figure S18 , where the resonance for the DCA -CCl 2 H proton is clearly smaller for the larger sample. ) is appreciable in all samples.
TGA analysis enabled quantification of DCA loading and an estimation of the structural composition. A comparison of the TGA traces for the four DCA@Zr-terephthalate MOFs with an empty Zr-terephthalate MOF can be found in Figure S20 . Individual TGA profile representations for each sample are given in Figure S21 , where DCA decomposition is inherently clear (ca. 250-375°C), and the estimated DCA content in weight percent is given in Table S6 . The experimental DCA and linker mass losses were compared to those calculated for theoretical model structures where DCA replaces linkers (Table S3) , in each case being close to the theoretical structure [Zr 6 O 4 (OH) 4 (L) 4 (DCA) 2 (OH) 2 ] n , indicating less defective structures than the smaller analogues (see Table S4 ). DCA Loadings are given in Table S5 .
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Figure S21. TGA profiles of the larger DCA-loaded terephthalate MOFs, showing DCA decomposition in the structure. 
S4. Colloidal Stability of DCA@MOFs
The particle size, aggregation and colloidal dispersion of the MOFs in water were measured by dynamic light scattering (DLS). In a scintillation vial, dispersion of the samples with a concentration of 0.1 mgmL -1 were prepared by sonication for 5 minutes prior to measurement. Each measurement consisted of 3 separated records, with a waiting time of 5 seconds. Each recording consisted of 14 runs, and no stirring was provided during the course of the experiment. The profiles for the small terephthalate nanoparticles are shown in Figure S22 . It is expected that in biological systems, formation of a protein corona will limit any aggregation. S8,S9 To examine this, DLS experiments were carried out on the samples that showed some aggregation -the smaller terephthalate MOFs as well as Zr-L5 and Zr-L6 -when dispersed in phosphate buffered saline (PBS, pH = 7.4) that had been "spiked" with 2% w/w bovine serum albumin (BSA), to mimic biological conditions. All samples showed less aggregation and improved colloidal stability, and are compared with the analogous experiments in water in Figures S26 and S27 . The smaller samples stabilised to around 100-150 nm aggregates, while DCA@Zr-L4 small appeared to be monodisperse and correlated well with particle sizes determined by SEM. The amino functionality of L4 is expected to be protonated under these conditions, and so likely forms a highly stable corona with the negatively charged BSA. The larger particles also formed stable dispersions close to the particle sizes determined by SEM, indicating that the MOFs will not be significantly aggregated during in vitro cytotoxicity studies. 
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S5. Therapeutic Efficiency of DCA@MOFs
The cytotoxicity of the DCA@MOFs and free DCA (in the form of sodium dichloroacetate, NaDCA, to negate cytotoxic effects of changing pH) was measured against MCF-7 breast carcinoma cells using the 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium (MTS, Promega, UK) reduction assay.
MCF-7 cells were maintained at 37 ºC with 5% CO 2 in high rich glucose (4500 mgL CO 2 . After 72 hours, the conditions were removed and the cells were washed once with phosphate buffered saline (PBS) to remove excess MOF, the media was replaced with 100 μL of fresh culture media containing 20 μL of MTS/phenazinemethosulfate (in a proportion 20:1) solution, and the plate was incubated for 1 h at 37 ºC with 5% CO 2 . Before reading the plates the plates at 490 nm by UV/vis spectrophotometry, the cell growth media was changed to a new plate to avoid false reading due to MOFs plate blockage.
The MTS assay for NaDCA is shown in Figure S28 , and confirms that DCA has little effect on cell proliferation. A dose-responsive cytotoxicity is evident, but only at very high concentrations, with 40.6 ± 18.2% viability after incubation with 9 mgmL -1 of NaDCA. This is in comparison with a maximum dose of 0.26 mgmL -1 DCA delivered by the DCA@MOFs (26.4% w/w loading of DCA in DCA@Zr-L4 small , incubated at 1 mgmL -1 MOF). After incubation with 0.5 mgmL -1 NaDCA, the viability of MCF-7 cells is 99.9 ± 26.0%, and we have previously shown the empty MOFs to be non-toxic, S6 thus, any cytotoxicity comes from enhanced delivery of DCA into the MCF-7 cells by the MOF nanoparticles. Figure S28 . Viability, as measured by MTS proliferation assay, of MCF-7 cells when incubated with different concentrations of sodium dichloroacetate for 72 h. Figure S29 shows the MCF-7 cell proliferation values when incubated with the larger DCAloaded nanoparticles, plotted against MOF concentration. The analogous chart plotted against DCA concentration is shown in Figure 3a in the manuscript, and absolute values are collated in Table S7 . 
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Zr-L1
DCA@
Zr-L2
DCA@
Zr-L3
DCA@
Zr-L4
DCA@
Zr-L5
DCA@
Zr-L6
0 100 ± 4.6 100 ± 11.5 100 ± 11.5 100 ± 11.5 100 ± 5.7 100 ± 5.7
0.25 108.3 ± 3.8 130.0 ± 16.4 123.5± 11.6 92.1 ± 14.5 87.2 ± 9.8 56.6 ± 5.9 0.5 101.9 ± 5.6 107.9 ± 14.8 121.8 ± 12.3 50.9 ± 12.9 56.2 ± 8.6 39.2 ± 10.1 0.75 113.3 ± 5.6 72.1 ± 13.6 118.2 ± 12.9 46.6 ± 12.1 31.9 ± 7.2 29.8 ± 5.6 1 110.7 ± 3.8 61.0± 15.7 80.8 ± 14.6 34.2 ± 11.5 30.0 ± 7.6 34.0 ± 7.7 Figure S30 shows a comparison of MCF-7 cell proliferation on incubation with the small and large terephthalate MOFs, plotted against MOF concentration. The analogous chart plotted against DCA concentration is given in Figure S31 (and partially in Figure 3b in the main text).
Absolute values from Figure S30 are collated in Table S8 . 
DCA@
Zr-L1
DCA@
Zr-L2
DCA@
Zr-L3
DCA@
Zr-L4
0 100 ± 4.6 100 ± 5.7 100 ± 5.7 100 ± 5.7 100 ± 4.6 100 ± 11.5 100 ± 11.5 100 ± 11.5 0.25 93.5 ± 7.2 83.6 ± 6.9 88.6 ± 5.6 92.0 ± 6.9 108.3 ± 3.8 130.0 ± 16.4 123.5± 11.6 92.1 ± 14.5 0.5 89.8 ± 6.3 58.8 ± 6.3 62.5 ± 7.3 72.4 ± 6.2 101.9 ± 5.6 107.9 ± 14.8 121.8 ± 12.3 50.9 ± 12.9 0.75 14.6 ± 3.8 47.3 ± 6.7 46.6 ± 5.4 57.0 ± 6.3 113.3 ± 5.6 72.1 ± 13.6 118.2 ± 12.9 46.6 ± 12.1 1 42.5 ± 15.7 36.0 ± 5.4 37.3 ± 5.7 47.6 ± 6.8 110.7 ± 3.8 61.0± 15.7 80.8 ± 14.6 34.2 ± 11.5 S30
S6. 5-FU Loading
The known anticancer drug 5-fluorouracil (5-FU) was loaded into the DCA-loaded MOFs to examine the effect of dual drug delivery and the reports that DCA can enhance the therapeutic efficiency of 5-FU. S10, S11
5-FU Loadings:
40 mg of the DCA@NMOF in question were sonicated during 15 minutes in a 5-FU solution (3 mgmL -1 in MeOH), and then the dispersion was stirred during 3 hours at room temperature. The 5-FU@DCA@NMOFs were collected by centrifugation and washed with MeOH (x2) through dispersion centrifugation cycles to ensure no residual 5-FU was present on the surfaces of the particles. The resultant NMOFs were dried under vacuum at least 24 hours before analysis.
FT-IR and NMR spectroscopies were again attempted to determine the extent of 5-FU loading.
1 H NMR spectra of acid digested samples showed that DCA was still present after loading, but only very low intensity signals were observed for 5-FU, indicating low loading.
Additionally, due to the very low content of 5-FU, its FT-IR vibration bands are masked by the MOF signals in the FT-IR spectra of the 5-FU@DCA@MOF samples. The characteristic vibration bands of DCA can still clearly be observed in the spectra ( Figure S32 ).
Thermogravimetric analysis of the samples ( Figure S33 ) is complicated by the fact that 5-FU and DCA thermally decompose in the same temperature region (250-375 °C). As such, it is not possible to quantify 5-FU loading using TGA.
To overcome this issue, a spectrophotometric protocol was developed to take advantage of the characteristic UV/Vis spectrum of 5-FU and allow determination of 5-FU loading values. 
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5-FU Loading Determination by UV-Vis Spectroscopy:
Since the main UV-Vis absorbance band of 5-FU (λ max = 266 nm) overlaps with the absorbance of L2 and L3 in particular, determination of 5-FU content through digestion of the samples in PBS is not possible. However, the MOFs are stable in methanol, showing minimal leakage and enabling 5-FU release and determination against a previously calculated calibration curve Around 2.5 mg of samples were dispersed in 5 mL of MeOH and sonicated for 2 minutes in order to promote 5-FU release, followed by 30 minutes stirring at room temperature. The supernatant was collected by centrifugation, and a UV/Vis spectrum measured from λ = 200-500 nm. The 5-FU content (λ max = 266 nm) in weight percent was calculated against a previously calculated calibration curve ( Figure S34 ). Additionally, absorbance measurements of the linkers in MeOH were performed, confirming minor or no linker leakage from the MOFs that did not affect 5-FU determination. UV/Vis spectra of 5-FU release are provided in Figure S35 , and loading values are given in Table 1 in the main manuscript. The calculations were performed using the exact mass of each MOF added. The samples were dispersed again and the measurements were repeated 2 hours after to ensure that 5-FU release was completed. Knowing the loading of 5-FU in the MOFs, it is therefore possible to estimate the DCA loading using the TGA traces shown in Figure S33 , if we assume that the mass loss in the temperature region (250-375 °C) corresponds to thermal decomposition of both DCA and 5-FU, and therefore deduct the 5-FU content, as determined by UV/Vis spectroscopy, from the total ( Table S9 ). The terephthalate-based MOFs lose significant quantities of DCA during 5-FU loading, but still retain respectable, clinically relevant contents. 
S7. Therapeutic Efficiency of 5-FU@DCA@MOFs
5-FU acts as a thymidylate synthase (TS) inhibitor, and thus needs to reach the nucleus of cancer cells to be effective, S12 while DCA inhibits pyruvate kinase and hence acts in the mitochondria. S13-S15 As such, the efficacy of both drugs depends on localisation in the cytosol after uptake, and so successful delivery of both drugs into the cytosol of cancer cells by one DDS may result in enhancement of therapeutic activity.
The MTS cell viability assays for MCF-7 cells incubated with 5-FU@DCA@MOFs were performed following the same protocol as in Section S5 for the DCA@MOFs. Additionally, the MTS assay was carried out against free 5-FU to determine its therapeutic efficiency. The results are plotted in Figure 4 in the main text and the absolute values tabulated in Table   S10 . Table S10 . MCF-7 cell viabilities when incubated with different concentrations of free 5-FU for 72 h. as in the Section S5 will result in delivery of very low quantities of 5-FU (see Table S11 ). The 5-FU concentrations achieved by the 5-FU@DCA@MOFs dispersed in growth media are in the range of non-cytotoxic and cytotoxic free 5-FU concentrations, which allows determination of any enhancement in cytotoxicity compared to free 5-FU. The results are plotted in Figure 4 in the main text and the absolute values collated in Table S12 . 
5-FU@ DCA@
Zr-L5
5-FU@ DCA@
Zr-L6
0 100 ± 4.6 100 ± 6.7 100 ± 6.7 100 ± 6.7 100 ± 6.7 100 ± 6.7 0.25 62.0 ± 13.5 77.3 ± 7.9 60.4 ± 8.6 85.1 ± 12.1 26.7 ± 6.6 4.0 ± 6.3 0.5 53.8 ± 8.0 55.6 ± 8.7 18.8 ± 6.7 33.1 ± 8.4 6.7 ± 6.3 3.7 ± 6.4 0.75 33.8 ± 8.4 40.1 ± 11.4 18.0 ± 7.3 6.2 ± 6.5 4.1 ± 6.3 5.0 ± 6.4 1 20.9 ± 7.3 21.2 ± 6.6 13.1 ± 6.7 2.4 ± 6.3 4.7 ± 6.5 5.4 ± 6.5
Control experiments were carried out to assess the enhancement in cytotoxicity when 5-FU and DCA are delivered in a bimodal fashion by the Zr MOFs. MTS assays on a new batch of MCF-7 cells were carried out in the presence of (i) free 5-FU, (ii) free 5-FU spiked with 0.1 mgmL -1 NaDCA, and (iii) free 5-FU spiked with 0.2 mgmL -1 NaDCA using the conditions described in Section S5. The addition of NaDCA was designed to mimic the concentrations of DCA delivered by the 5-FU@DCA@MOFs in the experiments described in Section S5;
the results are shown in Figure S36 and tabulated in Table S13 . The results are the same within experimental error, showing that no enhancement of 5-FU cytotoxicity occurs when administered with free DCA at these concentrations, which is presumably a consequence of the fact that DCA cannot efficiently cross the cell membrane without a suitable DDS.
Literature reports of enhanced 5-FU cytotoxicity when administered alongside DCA require concentrations of DCA one or two orders of magnitude higher than those delivered by the MOFs, S10, S11 again demonstrating the potential of MOFs to transport DCA across the cell membrane. 0.25 11.4 ± 8.6 11.5 ± 8.6
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Slightly different cytotoxicities of free 5-FU towards MCF-7 cells were observed at low 5-FU concentrations when compared to the data previously collected in Section S5, presumably as a consequence of these additional MTS assays being carried out on a completely new S38 batch of MCF-7 cells. When the average cell proliferation values from these two independent MTS assays are plotted against the cell proliferation values previously determined for the 5-FU@DCA@MOFs ( Figure S37 ), the trends described in the manuscript and in Section S5 are still evident, and the conclusions and hypotheses made do not change. These experiments show that, when comparing absolute values from MTS cell proliferation assays, it is important to collect data from assays run concurrently on the same batch of cells to ensure experimental error is reduced. The data presented in Figure 4b in the manuscript come from assays carried out on the same batch of cells at the same time, which should give a better comparison. 
